As heart, kidney and metabolic problems progress to more advanced stages, a person's risk of developing several cancers also ...
New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major ...
Researchers note that longer-term studies are needed to evaluate clinical outcomes such as heart attacks, strokes and ...
It is known that high blood sugar, high blood pressure, chronic kidney disease, and obesity, increase the risk of certain ...
We tend to treat dietary supplements as something natural and healthy – but the truth is that for some people they may be ...
BACKGROUND: Cardiovascular-kidney-metabolic (CKM) syndrome is a recently proposed framework emphasizing the interconnected ...
HCM causes the heart muscle to abnormally thicken, making it harder for the heart to pump blood effectively. According to the ...
GLP-1 weight loss drugs containing tirzepatide (Mounjaro, Zepbound) can reduce heart-related health risks for people with ...
A 2026 study found that making small, but intentional changes to your diet, exercise, and sleep habits can reduce your ...
The American Heart Association's Life's Essential 8 (LE8) score is a health tool, ranging from 0 to 100, that quantifies ...
Cardiovascular events don't strike out of the blue. Nearly all of them are preceded by warning signs
Nearly everyone who experiences a cardiovascular event — heart attacks, heart failure and strokes — exhibits at least one modifiable risk factor beforehand, new research shows. The study refutes the ...
Men are at a much higher risk of heart attacks than women earlier in life, a new study reveals. Researchers at Northwestern University found that men start to develop coronary heart disease years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results